Skip to main content
. 2022 Jun 21;2022(6):CD006404. doi: 10.1002/14651858.CD006404.pub4

3.2. Analysis.

3.2

Comparison 3: Pyronaridine‐artesunate versus mefloquine plus artesunate, Outcome 2: Total failure: day 42 (PCR‐adjusted)